Pourya Gholizadeh
1,2 
, Moussa Sanogo
3, Amadou Oumarou
4, Maad Nasser Mohamed
5, Yacouba Cissoko
6, Mamadou Saliou Sow
7, Pasquale Pagliano
8, Patassi Akouda
9, Sid’Ahmed Soufiane
10, Akory Ag Iknane
3,11, Mamadou Oury
7, Safiatou Diallo
7, Şükran Köse
12, Sounkalo Dao
3*, Hossein Samadi Kafil
2* 1 Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran
2 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
3 Faculté de Médecine, de Pharmacie et d’Odonto-Stomatologie (FMPOS), University of Bamako, Bamako, Mali
4 Faculte des sciences la santé de l universite Dan Dicko DanKoulodo de Maradi, Niger
5 Service des maladies infectieuses et tropicales de l’hôpital général peltier, Djibouti
6 Faculty of Medicine and Dentistry, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
7 Service des Maladies Infectieuses, Hôpital National Donka, CHU Conakry, Centre de Recherche et de Formation en Infectiologie de Guinée (CERFIG), Guinea
8 Departement of Medicine, University of Salerno, Salerno, Italy
9 CHU Sylvanus Olympio, Universitie delome, Togo
10 Faculte de Medecine de Nouakchott, Muritanie
11 Institut National de Santé Publique, Bamako, Mali
12 Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Tepecik Training and Research Hospital, İzmir, Turkey
Abstract
Coronavirus disease 2019 (COVID-19) dissemination occurred from December
2019 and quickly spread to all countries. Infected patients with COVID-19 have had a wide
range of symptoms, ranging from mild to severe illness. The most mortality was observed
in patients with underlying disease and over 45 years. World statistics have shown that the
COVID-19 outbreak is most expanded in Middle Eastern, West Asian, European, North, and
South American countries, and is least expanded in African countries. Therefore, the aim of the
paper was the evaluation of six African countries including Mali, Mauritania, Niger, Guinea,
Togo, and Djibouti to find why this disease is least expanded in African countries. Study
was conducted by Questioner for countries health organizers to define their different aspect
exposure and fight with COVID-19 including epidemiology, clinical aspects of the disease,
case definitions, diagnosis laboratory confirmation, and referral of cases by the portal of entry,
case management, and disease prevention in these countries. According to this opinion review,
due to the low international flights and low domestic travel, the spread, and prevalence of
COVID-19 was low and the return of the immigrants of these countries has caused the spread of
COVID-19 among these countries. Experience, preparation, and impact of previous infections
epidemic such as the Ebola virus epidemic would have beneficial, which have promoted certain
reflexes among people that cause low dissemination in these countries.